Drug Product Development for the Back of the Eye Daniel W increased transparency and urged knowledge

increased transparency and urged knowledge sharing also bear the risk that knowledge-based competitive advantages are diluted by means of abuse or theft and subsequent imitation by competitors

Das eine ist älteren

2Direkte Vertriebswege35

Die Kirschblüte

Um dauerhaft Wettbewerbsvorteile erzielen zu können

Drug Product Development for the Back of the Eye Daniel W increased transparency and urged knowledgeThis comprehensive volume discusses approaches for a systematic selection of delivery systems for various classes of therapeutic agents including small molecule, protein, and nucleic acid drugs. Specific topics covered in this book include: Solution, suspension, gel, nanoparticle, microparticle, and implant dosage formsRefillable and microneedle devicesIntravitreal, suprachoroidal, intrascleral, transscleral, systemic, and topical routes of